EJNMMI Res

First-in-class positron emission tomography tracer for the glucagon receptor.

Velikyan I, Haack T, Bossart M, ..., Wagner M, Eriksson O

EJNMMI Res 9 (1) 17 [2019-02-15; online 2019-02-15]

Olof Eriksson SciLifeLab Fellow

The development of a GPR44 targeting radioligand [11C]AZ12204657 for in vivo assessment of beta cell mass.

Jahan M, Johnström P, Selvaraju RK, ..., Halldin C, Eriksson O

EJNMMI Res 8 (1) 113 [2018-12-27; online 2018-12-27]

Olof Eriksson SciLifeLab Fellow

Strategy to develop a MAO-A-resistant 5-hydroxy-L-[β-(11)C]tryptophan isotopologue based on deuterium kinetic isotope effects.

Eriksson J, Åberg O, Selvaraju RK, ..., Johansson L, Eriksson O

EJNMMI Res 4 (1) 62 [2014-12-00; online 2014-11-30]

Olof Eriksson SciLifeLab Fellow

Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches.

Tegnebratt T, Ruge E, Bader S, ..., Tessier J, Stone-Elander S

EJNMMI Res 4 (1) 34 [2014-12-00; online 2014-09-09]

Affiliated researcher

Visualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[11C]PAQ.

Samén E, Lu L, Mulder J, ..., Rundqvist H, Stone-Elander S

EJNMMI Res 4 (1) 17 [2014-03-26; online 2014-03-26]

Affiliated researcher

Decreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PET.

Jahan M, Eriksson O, Johnström P, ..., Johansson L, Halldin C

EJNMMI Res 1 (1) 33 [2011-12-05; online 2011-12-05]

Olof Eriksson SciLifeLab Fellow